What were DuPont's second-quarter financial results, and how did they compare to the prior year and analyst expectations?

DuPont reported second-quarter net income of $191 million, a significant increase from $24 million in the year-ago quarter. Adjusted earnings per share (EPS) were $1.88 — 48% higher year over year and above the analysts’ consensus estimate of $1.76 per share. Net sales rose 4% year over year to $1.82 billion, with organic sales growth of 4% in healthcare and water technologies and 3% in diversified industrials.

How did DuPont's healthcare and water technologies segment perform in the second quarter, and what drove its growth?

The healthcare and water technologies segment’s operating EBITDA increased 4% year over year to $258 million on sales up 5% to $856 million; healthcare technologies sales grew by mid-single digits, led by personal protection and biopharma, while water technologies sales rose by low-single digits, supported by strength in industrial water and semiconductor markets despite weakness in the Middle East.